These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33240468)

  • 21. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer
    Gon├žalves PG; Reis RM; Bidinotto LT
    Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pan-cancer analysis of the role of
    Ding G; Ma T; Zhang K; Chen G; Shen J; Zhang S; Li K; Zhao C; Wang F; Sun J; Wang J
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-16. PubMed ID: 36971139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.
    Khan R; Pari B; Puszynski K
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
    Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
    BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10.
    Sun N; Li C; Teng Y; Deng Y; Shi L
    J Oncol; 2022; 2022():1242658. PubMed ID: 36276268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues.
    Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W
    Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
    Zhang Z; Li L; Li M; Wang X
    Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics and survival analysis of glia maturation factor-╬│ in pan-cancers.
    Lan A; Ren C; Wang X; Tong G; Yang G
    BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

  • 31. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
    Zhao C; Yu M; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuritin 1 expression in human normal tissues and its association with various human cancers.
    Dong H; Luo X; Niu Y; Yu N; Gao R; Wang H; Yang L; Huang J
    Int J Clin Exp Pathol; 2018; 11(4):1956-1964. PubMed ID: 31938301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 34. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors.
    Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C
    Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
    Fei L; Lu Z; Xu Y; Hou G
    Front Genet; 2022; 13():920897. PubMed ID: 36035140
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential Expression of the
    Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
    Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
    Ding Q; Li R; Wang Q; Yu L; Zi F
    Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.
    Wang Y; Zhang Y; Wang F; Li T; Song X; Shi H; Du J; Zhang H; Jing H; Han J; Tong D; Zhang J
    Sci Rep; 2022 Nov; 12(1):18518. PubMed ID: 36323715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
    Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME
    Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.